Dr. Kathy P Cook, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 Main St, Suite 113, Ames, IA 50010 Phone: 515-232-3006 Fax: 515-232-3009 |
Timothy James Hansen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3600 W Lincoln Way, Mcfarland Clinic, Pc, Ames, IA 50014 Phone: 515-239-4492 Fax: 515-663-4836 |
Leslie J Christenson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3600 W Lincoln Way, Mcfarland Clinic Pc, Ames, IA 50010 Phone: 515-239-4492 |
Dr. Anne Al Snider, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3600 Lincoln Way, Ames, IA 50014 Phone: 515-239-4492 Fax: 515-663-4836 |
News Archive
Using some of the most advanced molecular sequencing tools available to evaluate COVID-19 rapid autopsy tissues, researchers have identified four major regulatory pathways, specific molecular effectors behind COVID-19 symptoms, and differences that drive diverging clinical courses among individual patients.
Scientists have highlighted for the first time the plight of the growing number of older children and adolescents living with undiagnosed HIV and AIDS in Africa. In a study published today in Clinical Infectious Diseases, Wellcome Trust researchers claim that delay in recognising this problem means that the needs of this important group are not being met.
The Administrative Law Judge at the U.S. International Trade Commission (ITC) issued his Initial Determination concluding that Acambis plc's smallpox vaccine product (MVA3000) infringes two of Bavarian Nordic's patents on Modified Vaccinia Ankara (MVA) and furthermore that Bavarian Nordic's patents are enforceable.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today presented data that demonstrated patients treated for 10 and 15 years with COPAXONE® (glatiramer acetate injection) had significant reduction in disease severity. These data, generated from the longest continuous prospective study of any disease modifying therapy in relapsing remitting multiple sclerosis (RRMS), were presented today at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.
› Verified 1 days ago